All Therapeutic Areas
🎗️
Oncology
241 drugs in pipeline from 10 companies
241
Drugs in Pipeline
10
Companies
10
Upcoming Catalysts
241
Phase 3 Trials
Upcoming Catalysts
Jun '26
Jun '26
Jun '26
Jun '26
aglatimagene besadenovec + valacyclovir Phase 2 Results Expected
Aglatimagene besadenovec + valacyclovir30
Jun '26
IMM-1-104 Monotherapy (Treatment Group A) Phase 2 Est. Readout
IMM-1-104 Monotherapy (Treatment Group A)209
Pipeline by Phase
Phase 3
241
Active Companies
Related Conditions
cancertumorcarcinomalymphomaleukemiamelanomaoncologysarcomamyelomametastaticneoplasmmalignantbreast cancerlung cancerprostate cancercolorectalpancreaticglioblastomahepatocellularrenal cellovarianbladdernsclcsclcamlcllalldlbclhodgkinnon-hodgkin